I’m excited that Binance has expanded its collateral framework by adding four new bStocks tokenized securities—JPMorgan Chase (JPMB), Eli Lilly (LLYB), Securitize Corp (SECZB) and StablecoinX Inc (USDEB). This follows the seven bStocks added last month, giving traders a regulated on‑chain way to post high‑quality equity assets as margin 🚀. By tokenizing these equities, Binance bridges the gap between traditional markets and DeFi, enabling seamless margin management.

On the spot and Convert markets those four bStocks are now tradable directly against USDT, BUSD and other stablecoins. The new pairs boost liquidity, cut slippage and let both retail and institutional investors diversify their on‑chain portfolios with familiar stocks. The inclusion of both pharma and fintech tokens broadens sector exposure for on‑chain traders 📈.

Binance Futures is also launching several USDⓈ‑margined perpetual contracts, including the CTUSDT contract and a range of TradFi‑linked products. These contracts provide 24/7 exposure to traditional assets while leveraging crypto‑margin efficiency, a move I see expanding participation and cementing Binance’s leadership in tokenized finance. I anticipate that these USD‑margined products will attract hedge funds seeking continuous exposure without the overnight funding fees of traditional futures 💡.
$STRK, $MBL, $STRK